Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5262303 | 0.85 | SLC1A3 (0.55) | SLC1A3CYP1A2FAAHSIRT1ALDH1A1 | |
| SCHEMBL5262300 | 0.85 | SLC1A3 (0.55) | SLC1A3CYP1A2FAAHSIRT1ALDH1A1 | |
| SCHEMBL5854503 | 0.84 | SLC1A3 (0.52) | SLC1A3CYP1A2FAAHSIRT1ITGB3 | |
| SCHEMBL5854507 | 0.84 | SLC1A3 (0.52) | SLC1A3CYP1A2FAAHSIRT1ITGB3 | |
| SCHEMBL5855554 | 0.84 | SLC1A3 (0.52) | SLC1A3CYP1A2FAAHSIRT1ITGB3 | |
| SCHEMBL21802396 | 0.83 | SLC1A3 (0.54) | SLC1A3CYP1A2FAAHSIRT1MAPT | |
| SCHEMBL21802397 | 0.83 | SLC1A3 (0.54) | SLC1A3CYP1A2FAAHSIRT1MAPT | |
| SCHEMBL30502373 | 0.83 | SLC1A3 (0.54) | SLC1A3CYP1A2FAAHSIRT1ALDH1A1 | |
| SCHEMBL8604298 | 0.83 | CYP1A2 (0.57) | SLC1A3CYP1A2FAAHSIRT1ALDH1A1 | |
| SCHEMBL5261062 | 0.83 | SLC1A3 (0.51) | SLC1A3SIRT1ITGB3ITGA2BSIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11370812-B2 | Materials and methods for detection and quantification of β-N-methylamino-L-alanine | NORTH CAROLINA STATE UNIVERSITY (US) | 2022-06-28 | — | — | US | disclosed |
| US-20190241607-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF BETA N METHYLAMINO L ALANINE IN CU ZN SUPEROXIDE DISMUTASE 1 | UNIV NORTH CAROLINA STATE (US) | 2019-08-08 | — | — | US | disclosed |
| US-20190161515-A1 | MATERIALS AND METHODS FOR DETECTION AND QUANTIFICATION OF BETA-N-METHYLAMINO-L-ALANINE | NORTH CAROLINA STATE UNIVERSITY | 2019-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190241607-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF BETA N METHYLAMINO L ALANINE IN CU ZN SUPEROXIDE DISMUTASE 1 | SOD1, SOD3, BCAT1 | SLC1A3 96/4885CYP1A2 3207/4885FAAH 3801/4885 |
| US-20190161515-A1 | MATERIALS AND METHODS FOR DETECTION AND QUANTIFICATION OF BETA-N-METHYLAMINO-L-ALANINE | AADAT, BCAT1, BCAT2 | SLC1A3 64/4885CYP1A2 4580/4885FAAH 2228/4885 |
| US-11370812-B2 | Materials and methods for detection and quantification of β-N-methylamino-L-alanine | AADAT, BCAT1, BCAT2 | SLC1A3 59/4885CYP1A2 4602/4885FAAH 2250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.